Literature DB >> 26325631

Current controversies and challenges in allergic rhinitis management.

David Price1, Pete Smith2, Peter Hellings3, Nikos Papadopoulos4, Wytske Fokkens5, Antonella Muraro6, Ruth Murray7, Alison Chisholm8, Pascal Demoly9, Glenis Scadding10, Joaquim Mullol11, Phil Lieberman12, Claus Bachert13, Ralph Mösges14, Dermot Ryan15, Jean Bousquet16,17,18.   

Abstract

There are many obstacles in the path of effective allergy management, in general, and allergic rhinitis (AR) control, in particular. Chief among them are: insufficient symptom relief in some patients provided by some currently considered first-line AR treatments in real life; an over-reliance on randomized controlled trials to direct AR guideline recommendations; the need for a broader interpretation of the AR evidence base (to include randomized controlled trials and real-life studies); poorly designed and interpreted studies; and lack of an AR control concept and common language of control. These controversies are fully reviewed here and challenging solutions have been presented.

Entities:  

Keywords:  allergic rhinitis; clinical relevance; control; guidelines; randomized controlled trials; real life

Mesh：

Year:  2015        PMID： 26325631     DOI： 10.1586/1744666X.2015.1081814

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN： 1744-666X            Impact factor:   4.473


  10 in total

1.  Single nucleotide polymorphisms of IL-13 and CD14 genes in allergic rhinitis: a meta-analysis.

Authors:  Min-Li Chen; Hua Zhao; Qiu-Pin Huang; Zheng-Fu Xie
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-04-23       Impact factor: 2.503

2.  The Burden of Self-Reported Rhinitis and Associated Risk for Exacerbations with Moderate-Severe Asthma in Primary Care Patients.

Authors:  Vicky Kritikos; David Price; Alberto Papi; Antonio Infantino; Björn Ställberg; Dermot Ryan; Federico Lavorini; Henry Chrystyn; John Haughney; Karin Lisspers; Kevin Gruffydd-Jones; Miguel Román Rodríguez; Svein Høegh Henrichsen; Thys van der Molen; Victoria Carter; Sinthia Bosnic-Anticevich
Journal:  J Asthma Allergy       Date:  2020-10-06

3.  Genetic Variations in Nucleotide Excision Repair Pathway Genes and Risk of Allergic Rhinitis.

Authors:  Wenlong Liu; Qingxiang Zeng; Yinhui Zeng; Yiquan Tang; Renzhong Luo
Journal:  Mediators Inflamm       Date:  2022-06-03       Impact factor: 4.529

Review 4.  Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project.

Authors:  M A Calderon; P Demoly; T Casale; C A Akdis; C Bachert; M Bewick; B M Bilò; B Bohle; S Bonini; A Bush; D P Caimmi; G W Canonica; V Cardona; A M Chiriac; L Cox; A Custovic; F De Blay; P Devillier; A Didier; G Di Lorenzo; G Du Toit; S R Durham; P Eng; A Fiocchi; A T Fox; R Gerth van Wijk; R M Gomez; T Haathela; S Halken; P W Hellings; L Jacobsen; J Just; L K Tanno; J Kleine-Tebbe; L Klimek; E F Knol; P Kuna; D E Larenas-Linnemann; A Linneberg; M Matricardi; H J Malling; R Moesges; J Mullol; A Muraro; N Papadopoulos; G Passalacqua; E Pastorello; O Pfaar; D Price; P Rodriguez Del Rio; R Ruëff; B Samolinski; G K Scadding; G Senti; M H Shamji; A Sheikh; J C Sisul; D Sole; G J Sturm; A Tabar; R Van Ree; M T Ventura; C Vidal; E M Varga; M Worm; T Zuberbier; J Bousquet
Journal:  Clin Transl Allergy       Date:  2016-11-23       Impact factor: 5.871

5.  Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.

Authors:  Glenis Scadding; David Price; Tariq El-Shanawany; Shahzada Ahmed; Jaydip Ray; Ravishankar Sargur; Nirmal Kumar
Journal:  BMJ Open       Date:  2017-04-24       Impact factor: 2.692

6.  Unmet Primary Physicians' Needs for Allergic Rhinitis Care in Korea.

Authors:  Hyeon Jong Yang; Young Hyo Kim; Bora Lee; Do Youn Kong; Dong Kyu Kim; Mi Ae Kim; Bong Seong Kim; Won Young Kim; Jeong Hee Kim; Yang Park; So Yeon Park; Woo Yong Bae; Keejae Song; Min Suk Yang; Sang Min Lee; Young Mok Lee; Hyun Jong Lee; Jae Hong Cho; Hye Mi Jee; Jeong Hee Choi; Young Yoo; Young Il Koh
Journal:  Allergy Asthma Immunol Res       Date:  2017-05       Impact factor: 5.764

7.  Anti-Interleukin-9 Antibody Increases the Effect of Allergen-Specific Immunotherapy in Murine Allergic Rhinitis.

Authors:  Ji Hyeon Shin; Do Hyun Kim; Boo Young Kim; Sung Won Kim; Se Hwan Hwang; Joohyung Lee; Soo Whan Kim
Journal:  Allergy Asthma Immunol Res       Date:  2017-05       Impact factor: 5.764

8.  A patient-centric analysis to identify key influences in allergic rhinitis management.

Authors:  Biljana Cvetkovski; Rachel Tan; Vicky Kritikos; Kwok Yan; Elizabeth Azzi; Pamela Srour; Sinthia Bosnic-Anticevich
Journal:  NPJ Prim Care Respir Med       Date:  2018-09-13       Impact factor: 2.871

9.  Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care.

Authors:  Hilda J I De Jong; Jaco Voorham; Glenis K Scadding; Claus Bachert; Giorgio Walter Canonica; Peter Smith; Ulrich Wahn; Dermot Ryan; Jose A Castillo; Victoria A Carter; Ruth B Murray; David B Price
Journal:  World Allergy Organ J       Date:  2020-12-19       Impact factor: 4.084

10.  A multicenter, prospective, noninterventional study in a Norwegian cohort of patients with moderate-to-severe allergic rhinitis treated with MP-AzeFlu.

Authors:  Ralph Dollner; Petter Lorentz Larsen; Sinan Dheyauldeen; Sverre Steinsvåg
Journal:  Allergy Rhinol (Providence)       Date:  2017-10-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.